10x Genomics, Inc. — Director's Dealing 2021

May 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-05-03

Reporting Person: Hindson Benjamin J. (Director, See Remarks, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-03	Class A Common Stock	M	24080	$1.07	Acquired	60716	Direct
2021-05-03	Class A Common Stock	M	17586	$1.20	Acquired	78302	Direct
2021-05-03	Class A Common Stock	S	1492	$189.0732	Disposed	76810	Direct
2021-05-03	Class A Common Stock	S	4908	$190.1894	Disposed	71902	Direct
2021-05-03	Class A Common Stock	S	7905	$191.0681	Disposed	63997	Direct
2021-05-03	Class A Common Stock	S	20100	$192.1032	Disposed	43897	Direct
2021-05-03	Class A Common Stock	S	5361	$192.9553	Disposed	38536	Direct
2021-05-03	Class A Common Stock	S	800	$193.9674	Disposed	37736	Direct
2021-05-03	Class A Common Stock	S	500	$194.878	Disposed	37236	Direct
2021-05-03	Class A Common Stock	S	600	$197.91	Disposed	36636	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-03	Stock Option (right to buy)	$1.07	M	24080	Disposed	2026-11-18	Class A Common Stock (24080)	Direct
2021-05-03	Stock Option (right to buy)	$1.20	M	17586	Disposed	2027-10-18	Class A Common Stock (17586)	Direct

Footnotes

F1: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $188.51 to $189.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $189.57 to $190.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $190.57 to $191.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $191.57 to $192.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $192.59 to $193.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $193.75 to $194.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: This transaction was executed in multiple trades at prices ranging from $194.76 to $195.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F9: This transaction was executed in multiple trades at prices ranging from $197.55 to $198.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F10: All of the shares subject to the option are fully vested and exercisable as of the date hereof.

F11: This option, originally for 200,000 shares, of which 45,586 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2017 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.